Literature DB >> 12036446

Down-regulation of Gal 3-O-sulfotransferase-2 (Gal3ST-2) expression in human colonic non-mucinous adenocarcinoma.

Akira Seko1, Koji Nagata, Suguru Yonezawa, Katsuko Yamashita.   

Abstract

Expression levels of sulfomucin in human colonic adenocarcinomas are lower than those in normal colonic mucosa; this should be in part caused by down-regulation of expression of sulfotransferases, but it remains unclear which Gal 3-O-sulfotransferase (Gal3ST) is responsible for the biosynthesis of sulfomucin. In this study, we first examined the substrate specificities of four Gal3STs cloned so far, and found that Galbeta1 3GlcNAcbeta1 3Galbeta1 4Glc (LNT) can be utilized only by Gal3ST-2 as an acceptor substrate. The substrate specificity of Gal3ST-2 is closely similar to those of Gal3ST activities present in human normal mucosa and adenocarcinomas, suggesting that Gal3ST-2 is the dominant Gal3ST in colon and colonic cancer. Secondly, using LNT as a substrate, we comparatively analyzed levels of Gal3ST-2 activities in non-mucinous adenocarcinoma, mucinous adenocarcinomas, and the adjacent normal mucosa. We found that levels of Gal3ST-2 activities in non-mucinous adenocarcinoma are significantly lower than those in the adjacent normal mucosa, while those in mucinous adenocarcinomas are not significantly different from those in the adjacent normal mucosa. Moreover, we showed by a competitive RT-PCR method that expression levels of transcript for Gal3ST-2 in non-mucinous adenocarcinoma are lower than those in normal mucosa. These results suggest that Gal3ST-2 is one of the enzymes responsible for biosynthesis of sulfomucin, and that expression levels of Gal3ST-2 are down-regulated in non-mucinous adenocarcinoma.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12036446      PMCID: PMC5927024          DOI: 10.1111/j.1349-7006.2002.tb01285.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


Galβ1→4GlcNAcβ1→2Manα1→3(Galβ1 →4GlcNAcβ1 →2Manα1→6)Manβ1→4GlcNAcβ1→4GlcNAc benzyl carcinoembryonic antigen Galβ1→3GalNAc Galβ1→3(GlcNAcβ1→6)GalNAc dimethylsulfoxide fucose galactose galactosyl 1‐alkyl‐2‐acyl‐sn‐glycerol galactose 3‐O‐sulfotransferase galactosylceramide N‐acetyl‐galactosamine glyceraldehyde 3‐phosphate dehydrogenase glucose N‐acetylglucosamine Galβ1→4Glcβ1‐O‐pNP Galβ1→3GlcNAcβ1→3Galβ1→4Glc adenosine 3′‐phosphate 5′‐phosphosulfate p‐nitrophenyl reverse transcription‐polymerase chain reaction Sulfotransferase thin layer chromatography Galβ1→3GlcNAc Galβ1→4GlcNAc
  29 in total

1.  A novel human Gal-3-O-sulfotransferase: molecular cloning, characterization, and its implications in biosynthesis of (SO(4)-3)Galbeta1-4(Fucalpha1-3)GlcNAc.

Authors:  F M El-Fasakhany; K Uchimura; R Kannagi; T Muramatsu
Journal:  J Biol Chem       Date:  2001-05-16       Impact factor: 5.157

2.  Molecular cloning and expression of a novel human beta-Gal-3-O-sulfotransferase that acts preferentially on N-acetyllactosamine in N- and O-glycans.

Authors:  A Suzuki; N Hiraoka; M Suzuki; K Angata; A K Misra; J McAuliffe; O Hindsgaul; M Fukuda
Journal:  J Biol Chem       Date:  2001-04-25       Impact factor: 5.157

3.  Molecular cloning and expression of cDNA encoding human 3'-phosphoadenylylsulfate:galactosylceramide 3'-sulfotransferase.

Authors:  K Honke; M Tsuda; Y Hirahara; A Ishii; A Makita; Y Wada
Journal:  J Biol Chem       Date:  1997-02-21       Impact factor: 5.157

4.  cDNA cloning, genomic cloning, and tissue-specific regulation of mouse cerebroside sulfotransferase.

Authors:  Y Hirahara; M Tsuda; Y Wada; K Honke
Journal:  Eur J Biochem       Date:  2000-04

5.  An assay method for ganglioside synthase using anion-exchange chromatography.

Authors:  M Kawano; K Honke; M Tachi; S Gasa; A Makita
Journal:  Anal Biochem       Date:  1989-10       Impact factor: 3.365

6.  Expression cloning of a novel alpha 1,3-fucosyltransferase that is involved in biosynthesis of the sialyl Lewis x carbohydrate determinants in leukocytes.

Authors:  K Sasaki; K Kurata; K Funayama; M Nagata; E Watanabe; S Ohta; N Hanai; T Nishi
Journal:  J Biol Chem       Date:  1994-05-20       Impact factor: 5.157

7.  Specificity analysis of three clonal and five non-clonal alpha 1,3-L-fucosyltransferases with sulfated, sialylated, or fucosylated synthetic carbohydrates as acceptors in relation to the assembly of 3'-sialyl-6'-sulfo Lewis x (the L-selectin ligand) and related complex structures.

Authors:  E V Chandrasekaran; R K Jain; R D Larsen; K Wlasichuk; R A DiCioccio; K L Matta
Journal:  Biochemistry       Date:  1996-07-09       Impact factor: 3.162

8.  Characterization of a novel mucin sulphotransferase activity synthesizing sulphated O-glycan core 1,3-sulphate-Gal beta 1-3GalNAc alpha-R.

Authors:  W Kuhns; R K Jain; K L Matta; H Paulsen; M A Baker; R Geyer; I Brockhausen
Journal:  Glycobiology       Date:  1995-10       Impact factor: 4.313

9.  Structure of the O-glycans in GlyCAM-1, an endothelial-derived ligand for L-selectin.

Authors:  S Hemmerich; H Leffler; S D Rosen
Journal:  J Biol Chem       Date:  1995-05-19       Impact factor: 5.157

10.  Expression of sulfomucins in normal mucosae, colorectal adenocarcinomas, and metastases.

Authors:  Y Matsushita; N Yamamoto; H Shirahama; S Tanaka; S Yonezawa; T Yamori; T Irimura; E Sato
Journal:  Jpn J Cancer Res       Date:  1995-11
View more
  10 in total

1.  Galectin-8-N-domain recognition mechanism for sialylated and sulfated glycans.

Authors:  Hiroko Ideo; Tsutomu Matsuzaka; Takamasa Nonaka; Akira Seko; Katsuko Yamashita
Journal:  J Biol Chem       Date:  2011-02-02       Impact factor: 5.157

2.  Distinct substrate specificities of human GlcNAc-6-sulfotransferases revealed by mass spectrometry-based sulfoglycomic analysis.

Authors:  Shin-Yi Yu; Cheng-Te Hsiao; Mineko Izawa; Akiko Yusa; Hiroji Ishida; Shigeo Nakamura; Hirokazu Yagi; Reiji Kannagi; Kay-Hooi Khoo
Journal:  J Biol Chem       Date:  2018-08-09       Impact factor: 5.157

3.  Porcine, mouse and human galactose 3-O-sulphotransferase-2 enzymes have different substrate specificities; the porcine enzyme requires basic compounds for its catalytic activity.

Authors:  Akira Seko; Jun-ichi Sumiya; Katsuko Yamashita
Journal:  Biochem J       Date:  2005-10-01       Impact factor: 3.857

Review 4.  Selectins and selectin ligands in extravasation of cancer cells and organ selectivity of metastasis.

Authors:  Stéphanie Gout; Pierre-Luc Tremblay; Jacques Huot
Journal:  Clin Exp Metastasis       Date:  2007-09-21       Impact factor: 5.150

5.  Exome sequencing in one family with gastric- and rectal cancer.

Authors:  Jessada Thutkawkorapin; Simone Picelli; Vinaykumar Kontham; Tao Liu; Daniel Nilsson; Annika Lindblom
Journal:  BMC Genet       Date:  2016-02-13       Impact factor: 2.797

6.  Unveiling new interdependencies between significant DNA methylation sites, gene expression profiles and glioma patients survival.

Authors:  Michal J Dabrowski; Michal Draminski; Klev Diamanti; Karolina Stepniak; Magdalena A Mozolewska; Paweł Teisseyre; Jacek Koronacki; Jan Komorowski; Bozena Kaminska; Bartosz Wojtas
Journal:  Sci Rep       Date:  2018-03-13       Impact factor: 4.379

7.  A genome-wide cross-trait analysis from UK Biobank highlights the shared genetic architecture of asthma and allergic diseases.

Authors:  Zhaozhong Zhu; Phil H Lee; Mark D Chaffin; Wonil Chung; Po-Ru Loh; Quan Lu; David C Christiani; Liming Liang
Journal:  Nat Genet       Date:  2018-05-21       Impact factor: 38.330

8.  Human Milk Oligosaccharides Differently Modulate Goblet Cells Under Homeostatic, Proinflammatory Conditions and ER Stress.

Authors:  Lianghui Cheng; Chunli Kong; Marthe T C Walvoort; Marijke M Faas; Paul de Vos
Journal:  Mol Nutr Food Res       Date:  2019-12-11       Impact factor: 5.914

Review 9.  Molecular mechanism for cancer-associated induction of sialyl Lewis X and sialyl Lewis A expression-The Warburg effect revisited.

Authors:  Reiji Kannagi
Journal:  Glycoconj J       Date:  2004       Impact factor: 3.009

Review 10.  Genetics and Epigenetics in Allergic Rhinitis.

Authors:  Bo Yoon Choi; Munsoo Han; Ji Won Kwak; Tae Hoon Kim
Journal:  Genes (Basel)       Date:  2021-12-17       Impact factor: 4.096

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.